A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial
Saved in:
| Title: | A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial |
|---|---|
| Authors: | Chevallier, Patrice1 patrice.chevallier@chu-nantes.fr, Hunault-Berger, Mathilde2, Larosa, Fabrice3, Dauriac, Charles4, Garand, Richard2, Harousseau, Jean-Luc1 |
| Source: | Leukemia Research. Aug2009, Vol. 33 Issue 8, p1124-1126. 3p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 39782524 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Chevallier%2C+Patrice%22">Chevallier, Patrice</searchLink><relatesTo>1</relatesTo><i> patrice.chevallier@chu-nantes.fr</i><br /><searchLink fieldCode="AR" term="%22Hunault-Berger%2C+Mathilde%22">Hunault-Berger, Mathilde</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Larosa%2C+Fabrice%22">Larosa, Fabrice</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Dauriac%2C+Charles%22">Dauriac, Charles</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Garand%2C+Richard%22">Garand, Richard</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Harousseau%2C+Jean-Luc%22">Harousseau, Jean-Luc</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+Research%22">Leukemia Research</searchLink>. Aug2009, Vol. 33 Issue 8, p1124-1126. 3p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=39782524 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.leukres.2008.09.030 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 3 StartPage: 1124 Titles: – TitleFull: A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chevallier, Patrice – PersonEntity: Name: NameFull: Hunault-Berger, Mathilde – PersonEntity: Name: NameFull: Larosa, Fabrice – PersonEntity: Name: NameFull: Dauriac, Charles – PersonEntity: Name: NameFull: Garand, Richard – PersonEntity: Name: NameFull: Harousseau, Jean-Luc IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: Aug2009 Type: published Y: 2009 Identifiers: – Type: issn-print Value: 01452126 Numbering: – Type: volume Value: 33 – Type: issue Value: 8 Titles: – TitleFull: Leukemia Research Type: main |
| ResultId | 1 |